Sign In
Buy CPIX
$5.61
-0.160 (-2.77%)
At Close: Jun 03, 2026
Cumberland Expands Global Reach With Vibativ Launch in China
10:11am, Tuesday, 02'nd Jun 2026
CPIX launches Vibativ in China through SciClone, expanding access to its antibiotic treatment for serious Gram-positive bacterial infections.
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
09:05am, Tuesday, 02'nd Jun 2026
Positive Results from Phase 2a Clinical Trial Study met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumors Trial revealed promising effica
Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolavirus sub-type, for which there are no approved medications or vaccines, RedHill Biopharma is actively d
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA
09:05am, Thursday, 28'th May 2026
Commercialization in China through partnership with SciClone Pharmaceuticals Expands access to potentially life-saving antibiotic in the world's second-largest pharmaceutical market NASHVILLE, Tenn.
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
11:15am, Wednesday, 06'th May 2026
CPIX posts a wider y//y loss in Q1, as it unveils a $100-million Apotex deal and sharpens focus on orphan drug development.
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2026 Earnings Call Transcript
02:31am, Wednesday, 06'th May 2026
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2026 Earnings Call Transcript
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
05:00pm, Tuesday, 05'th May 2026
Enters into Strategic Transaction, unlocking $100 million in value Sharpens focus on Orphan Drug candidates to address unmet medical needs NASHVILLE, Tenn., May 5, 2026 /PRNewswire/ -- Cumberland Phar
RHB-2041 is a next-generation optimized formulation of RedHill's oral RHB-104 2 , designed for enhanced tolerability, safety profile and patient adherence, that employs a groundbreaking Mycobacterium
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
04:05pm, Tuesday, 28'th Apr 2026
NASHVILLE, Tenn., April 28, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2026 financi
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
08:00am, Monday, 27'th Apr 2026
2025 was a year of tenacity, strategic transactions and building traction for RedHill Talicia® business transformed: Formation of Talicia Holdings Inc. (THI) and the U.S. co-commercialization partne
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
09:00am, Thursday, 23'rd Apr 2026
Transaction unlocks $100 million in value for Cumberland Sharpens focus on Orphan Drug Candidates to address Unmet Medical Needs NASHVILLE, Tenn., April 23, 2026 /PRNewswire/ -- Cumberland Pharmaceuti
New preclinical data, independently presented in two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, show positive effects of opaganib [1] as potential add-on thera
CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
09:05am, Thursday, 16'th Apr 2026
A Safe and Effective Non-Opioid Pain Management Solution NASHVILLE, Tenn., April 16, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today anno
Cumberland Pharmaceuticals (NASDAQ:CPIX) & China SXT Pharmaceuticals (NASDAQ:SXTC) Head-To-Head Analysis
02:02am, Monday, 06'th Apr 2026
China SXT Pharmaceuticals (NASDAQ: SXTC - Get Free Report) and Cumberland Pharmaceuticals (NASDAQ: CPIX - Get Free Report) are both small-cap medical companies, but which is the superior investment? W
Sancuso – the Difference Between Life and Living NASHVILLE, Tenn., March 17, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company today announced t
